UNSPSC 51162308: Acetaminophen/caffeine/phenylpropanolamine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162308 Acetaminophen/caffeine/phenylpropanolamine/salicylamide is a Commodity code whose recent state and local activity reflects procurement of injectable pharmaceutical products and medical supplies for correctional and public health settings, diverging from the narrow scope implied by the code name. The Washington State Department of Corrections solicited parenteral nutrition solutions, intravenous solutions, and other injectable parenteral products including controlled substances for incarcerated individuals under RFQ RFQQK13020, due October 7, 2026. Issuing bodies under this code include state correctional departments and county public health authorities. Scope of work encompasses sourcing, preparation, and delivery of parenteral solutions with strict time-to-delivery requirements—parenteral nutrition bags within 24 hours of order, other parenteral products within 8 hours for the first supply—and demonstrated capability in IV solution preparation, patient lab monitoring, and nutrition formula adjustment.

Recent activity appears concentrated in the Pacific Northwest and Southeast. The Washington State Department of Corrections RFQ covers eight facilities across three regions (West, Central, and East) with an initial contract term through June 30, 2030 and fixed pricing for the first two years. DOC anticipates awarding up to three contractors per region. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, for naloxone and drug deactivation systems (1,900 units and 800 systems annually, respectively), with quarterly deliveries to the Seminole County Community Health Building in Sanford, though the due date listed (July 26, 2023) appears inconsistent with the posted date. Both opportunities require standard compliance certifications including drug-free workplace verification and E-Verify confirmation; the Washington solicitation emphasizes small-business, minority-owned, women-owned, and veteran-owned business participation and mandates documented subcontractor inclusion plans with diverse-business targets.